IMMUNE THERAPEUTICS

immune-therapeutics-logo

At Immune Therapeutics (formerly known as TNI BioTech, Inc.), their goal is to benefit patients with chronic and often life-threatening diseases through the activation and rebalancing of the body's immune system using our patented immunotherapy. Their products, technologies, and patents are designed to harness the power of the immune system to improve the treatment of cancer and infections, such as HIV/AIDS and autoimmune diseases. We are currently developing active and adoptive forms of immunotherapy. Immune Therapeutics' most advanced clinical programs involve immunotherapy with methionine-enkephalin (MENK) or low-dose naltrexone, which both work by triggering opioid receptors on immune cells and lead to the activation and expansion of various cells in the immune system.

#People #Financial #Event #Website #More

IMMUNE THERAPEUTICS

Industry:
Biotechnology Health Care Medical

Founded:
1993-12-02

Address:
Bethesda, Maryland, United States

Country:
United States

Website Url:
http://www.immunetherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
(888) 613-8802

Email Addresses:
[email protected]

Total Funding:
2.89 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome



Current Advisors List

stephen-wilson_image

Stephen Wilson Board of Directors @ Immune Therapeutics
Board_member
2022-07-01

Current Employees Featured

not_available_image

Ronald Herberman
Ronald Herberman Senior V.P. of R&D & Chief Medical Officer @ Immune Therapeutics
Senior V.P. of R&D & Chief Medical Officer

not_available_image

Christopher Pearce
Christopher Pearce Director & Chief Financial Officer @ Immune Therapeutics
Director & Chief Financial Officer

not_available_image

Fengping Shan
Fengping Shan Director & Chief Science Officer @ Immune Therapeutics
Director & Chief Science Officer

kelly-wilson_image

Kelly Wilson
Kelly Wilson Chief Operating Officer @ Immune Therapeutics
Chief Operating Officer
2022-08-01

stephen-wilson_image

Stephen Wilson
Stephen Wilson CEO, President and interim Chief Financial Officer @ Immune Therapeutics
CEO, President and interim Chief Financial Officer
2022-07-01

glen-farmer_image

Glen Farmer
Glen Farmer CFO @ Immune Therapeutics
CFO
2022-08-01

Founder


noreen-griffin_image

Noreen Griffin

Stock Details


Company's stock symbol is OTCQB:IMUN

Acquisitions List

Date Company Article Price
2019-12-16 Aletheia Therapeutics Aletheia Therapeutics acquired by Immune Therapeutics N/A

Official Site Inspections

http://www.immunetherapeutics.com

  • Host name: 208.91.197.195
  • IP address: 208.91.197.195
  • Location: British Virgin Islands
  • Latitude: 18.5
  • Longitude: -64.5
  • Timezone: America/Tortola

Loading ...

More informations about "Immune Therapeutics" on Search Engine